Matthew Isaac Lyons

Matthew Lyons practices at Concord Medical Center in Concord, California, part of John Muir Health.

Matthew Lyons' NPI, 1457714933, was assigned on April 1, 2016. Matthew Lyons graduated from Paul L. Foster School of Medicine in 2016. Matthew Lyons holds California license A167951.

Matthew Lyons' primary practice is Concord Medical Center, at 2540 East St, Concord, CA 94520 in Contra Costa County. The practice phone is (925) 682-8200.

Matthew Lyons' primary practice is Concord Medical Center in Concord, California, part of John Muir Health. Matthew Lyons is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is John Muir Health. Dmand AI also links Matthew Lyons to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Lyons practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Matthew Lyons' primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Matthew Lyons is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Matthew Lyons' licenses on file in 2 states: California and Ohio.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia and sleep apnea among the conditions Matthew Lyons treats.

CMS data shows 2,300 Medicare services from Matthew Lyons across 32 procedure codes in 2024, for 613 Medicare patients. Medicare paid $240,261 for them.

CMS counts 613 Medicare patients who saw Matthew Lyons in 2024. The largest group is 75 to 84, with 227 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Matthew Lyons' median patient age at 64, with 48% women.

In 2024, Matthew Lyons wrote 604 Medicare Part D claims for 137 patients. 42% of them were for generic drugs. CMS names the drug for 436 of them, across 15 drugs with 11 or more claims each, at $367,701 in total drug cost. In 2023, CMS named 155 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Matthew Lyons for performance year 2024, reported as part of a group. Matthew Lyons accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Matthew Lyons as offering telehealth.

Dmand AI links 4 papers to Matthew Lyons, published from 2017 to 2023. Matthew Lyons' most frequent co-authors are Salem Almaani, MD, Alexis K. Barnes, MD and Elliott D. Crouser, MD.

CMS Open Payments shows 32 general payments to Matthew Lyons from 16 drug and device companies from 2023 to 2025. Education make up the largest share, 51% of the total. Intuitive Surgical, Inc. paid the most, $2,843.

Matthew Lyons graduated from Paul L. Foster School of Medicine in 2016.

Matthew Lyons is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.